1[1]Notelovitz M.Estrogen therapy and osteoporosis:principles and paractice.Am J Med Sci.1997,313:2-12.
2[2]Licata AA.Bisphosphonate therapy.Am J Med Sci.1997,313:17-22.
3[3]Lynch MP,Stein JL,Stein GS et al.The influence of collagen type Ⅰ on the development and maintenance of the osteoblasts phenotype in primary and passaged rat calvarial osteoblasts:modification of expression gene supporting cell growth,adhesion and extracellular matrix mineralization.Exp Cell Res,1995,216(1):35-45.
4[4]Scott DB,Liu YS,Hair GA,et al.LMP-1,A LIM-domain protein,mediates BMP-6 effects on bone formation.Endocrinology,1998,139:5125-5134.
5[5]Kim CH,Cheng SL,Kim GS.Effects of dexamethasone on proliferation,activity and cytokine secretion of normal human bone marrow stromal cells: possible mechanism of glucocorticoid-induced bone loss.J Endocrinol,1999,162:371-379.
6[6]Watts NB.Clinical utility of biochemical markers of bone remodeling.Clin Chem,1999,45:1359-1368.
7[7]Agnusdei D,Camporeale A,Zacchei F,et al.Effects of ipriflavone on bone mass and bone remodeling in patients with established postemeopausal osteoporosis.Curr Therap Res,1992,51:82-91.
8[8]Benvenuti S,Tanini A,Frediani U,et al.Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line.J Bone Miner Res,1991,6:987-994.
